MDMA and zero LDL-C - Peter Attia

Most interesting to me this week, a paper just published in The Lancet Psychiatry suggested that MDMA-assisted psychotherapy were effective and well-tolerated in reducing PTSD symptoms in veterans and first responders. The New York Times covered it here. This drug has shown a lot of promise in the treatment of PTSD: the FDA granted MDMA-assisted psychotherapy breakthrough therapy designation (which could expedite approval), and a Phase 3 clinical trial is in motion.

Another interesting read is the “zero LDL-cholesterol hypothesis” paper (it’s behind a paywall) recently published in the Journal of Clinical Lipidology. I hope to dig into this one in more detail soon…maybe on the podcast with a lipidology expert.

– Peter

Disclaimer: This blog is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this blog or materials linked from this blog is at the user's own risk. The content of this blog is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard, or delay in obtaining, medical advice for any medical condition they may have, and should seek the assistance of their health care professionals for any such conditions.

Other Content You May Like